drugset / Trial / NCT03348735

Localized Neuropathic Pain: Topical Treatment Versus Systemic Treatment

NCT03348735

Phase 4 Terminated 33 enrolled University Hospital, Antwerp
RandomizedParallel-groupDouble-blindTreatment

Summary

Evaluation of topical treatment with lidocaine 5% patch (daily administration) or capsaicin 8% patch (periodic administration - upon reoccurrence of pain symptoms) in adult patients suffering from localized neuropathic pain (LNP) across a wide variety of etiologies, with a duration between 1 and 24 months (subacute to chronic neuropathic pain (NP)).

Timeline

Start
2018-12-03
Primary completion
2021-04-19
Completion
2021-04-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Capsaicin Small molecule 8 %
Subject Lidocaine Other / unclassified 5 % Topical
Comparator Pregabalin Small molecule 75 mg Oral

Indications